Enanta Pharmaceuticals (ENTA) Property, Plant & Equipment (Net) Growth (3y) (2015 - 2026)
Enanta Pharmaceuticals (ENTA) Property, Plant & Equipment (Net) Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -9.89% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 21.04% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 13.10% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 10.71% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Enanta Pharmaceuticals | 369.97 Mn | 206.20 Mn | - | 44.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.17% |
| Dec 31, 2025 | 58.10% |
| Sep 30, 2025 | 78.98% |
| Jun 30, 2025 | 99.84% |
| Mar 31, 2025 | 98.35% |
| Dec 31, 2024 | 90.15% |
| Sep 30, 2024 | 76.52% |
| Jun 30, 2024 | 55.89% |
| Mar 31, 2024 | 30.05% |
| Dec 31, 2023 | 15.88% |
| Sep 30, 2023 | 11.51% |
| Jun 30, 2023 | 8.97% |
| Mar 31, 2023 | 4.30% |
| Dec 31, 2022 | -5.86% |
| Sep 30, 2022 | -17.33% |
| Jun 30, 2022 | -26.11% |
| Mar 31, 2022 | -25.14% |
| Dec 31, 2021 | -16.96% |
| Sep 30, 2021 | -10.80% |
| Jun 30, 2021 | -7.60% |